QuadMedicine, Inc. (KOSDAQ:464490)
South Korea
· Delayed Price · Currency is KRW
14,010
-320 (-2.23%)
At close: Apr 28, 2026
QuadMedicine Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Revenue | 10,698 | 9,304 | 1,012 |
| Revenue Growth (YoY) | 14.99% | 819.58% | - |
| Gross Profit | 10,698 | 9,304 | 1,012 |
| Selling, General & Admin | 1,826 | 1,337 | 1,413 |
| Research & Development | 15,014 | 12,269 | 9,006 |
| Other Operating Expenses | 73.63 | 2.75 | 2.91 |
| Operating Expenses | 17,082 | 13,753 | 10,531 |
| Operating Income | -6,384 | -4,449 | -9,519 |
| Interest Expense | -349.97 | -370.45 | -114.15 |
| Interest & Investment Income | 90.26 | 23.9 | 107.11 |
| Currency Exchange Gain (Loss) | -42.06 | 129.9 | 20.89 |
| Other Non Operating Income (Expenses) | -228.99 | -302.32 | -249.92 |
| EBT Excluding Unusual Items | -6,915 | -4,968 | -9,755 |
| Gain (Loss) on Sale of Assets | -16.34 | - | -3.14 |
| Pretax Income | -6,931 | -4,968 | -9,759 |
| Net Income | -6,931 | -4,968 | -9,759 |
| Net Income to Common | -6,931 | -4,968 | -9,759 |
| Shares Outstanding (Basic) | 10 | 9 | 9 |
| Shares Outstanding (Diluted) | 10 | 9 | 9 |
| Shares Change (YoY) | 10.16% | 0.94% | - |
| EPS (Basic) | -721.76 | -569.92 | -1129.97 |
| EPS (Diluted) | -722.00 | -570.00 | -1130.00 |
| Free Cash Flow | -6,738 | -2,214 | -10,056 |
| Free Cash Flow Per Share | -701.66 | -253.98 | -1164.44 |
| Gross Margin | 100.00% | 100.00% | 100.00% |
| Operating Margin | -59.67% | -47.82% | -940.90% |
| Profit Margin | -64.79% | -53.40% | -964.54% |
| Free Cash Flow Margin | -62.98% | -23.80% | -993.97% |
| EBITDA | -3,088 | -1,297 | -7,448 |
| EBITDA Margin | -28.87% | -13.94% | - |
| D&A For EBITDA | 3,296 | 3,153 | 2,071 |
| EBIT | -6,384 | -4,449 | -9,519 |
| EBIT Margin | -59.67% | -47.82% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.